Bill Detail
H.R. 7837
Congress: 119
Title
Most Favored Patient Act of 2026
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Rep. Daniel Meuser [R-PA-9]
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Status as of Jun 29, 12:35 PM · synced 8h ago
Introduced
2026-03-05
Data source mode: cache
Bill Engagement
Most Favored Patient Act of 2026
Sponsor
Rep. Daniel Meuser [R-PA-9]R
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Cosponsors
Solely sponsored — no cosponsors yet
LDA engagement
3 orgs · 3 filings
Top: Pharmaceutical Research and Manufactur…
Introduced
2026-03-05
Lobbyists on the case
3 orgs · 39 lobbyists · 3 filings mention H.R. 7837 (Most Favored Patient Act of 2026) in LDA disclosures.
Top orgs filing
- Pharmaceutical Research and Manufacturers of America1 filing · 22 lobs
- America's Health Insurance Plans, Inc. (AHIP)1 filing · 12 lobs
- Pfizer Inc.1 filing · 5 lobs
Lobbyists on this bill
- Meredith Allison2026 Q1Pharmaceutical Research and Manufacturers of America · Intern - Senator Richard Burr; Intern - Senator Roger Wicker
- Gary Beck2026 Q1
- Teresa Bill2026 Q1
- Francisco Carrillo2026 Q1
- Elenora Connors2026 Q1
- Sean Dickson2026 Q1
- Catherine Douglas2026 Q1
- Sean Dugan2026 Q1
+ 31 more